BioNano Genomics Readies Nanochannel Array Platform for SV Analysis, Genome Assembly | GenomeWeb

This article has been updated to note a wider price for a high-end microarray scanner.

Following a series of corporate changes over the last year and a new round of financing last month, BioNano Genomics is about to start beta testing for its nanochannel-based single-molecule DNA mapping platform.

The San Diego-based company will initially market the instrument, called Irys, for structural variation analysis and de novo genome assembly, though other uses, for example epigenetic mapping or pathogen fingerprinting, are feasible.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.